MedTrace Logo

Study for Evaluating Life Quality in Patients With Rhinoconjunctivitis

NCT02488447 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 215

Last updated 2017-10-20

No results posted yet for this study

Summary

The purpose of ths study is to evaluate changes in life quality of patients affected by rhinoconjuntivitis with or without asthma after immunotherapy treatment. It is an observational, prospective and comparative study before-after immunotherapy treatment with a one year follow-up.

Conditions

  • Allergic Rhinoconjunctivitis

Sponsors & Collaborators

  • Roxall Medicina España S.A

    lead INDUSTRY

Principal Investigators

  • Francisco Javier Fernández Arbeiza, Dr. · Complejo Hospitalario de Cáceres

  • Eloína González Mancebo, Dra. · Hospital Universitario de Fuenlabrada

  • Vanesa Sánchez, Dra. · Hospital Universitario del Henares

  • Jose Julio Laguna, Dr. · Hospital Central de la Cruz Roja

  • Alicia Alonso, Dra. · Centro Médico Alianza Médica

  • Ana Mª Callejo, Dra. · Hospital Virgen de la Concha

  • Mª Jesús Trujillo, Dra. · Hospital del Tajo

  • Ruth Mielgo, Dra. · Hospital 12 de Octubre

  • Javier Cuesta, Dr. · Hospital Fundación Jiménez Díaz

  • Mónica Rodríguez, Dra. · Hospital Fundación Alcorcón

  • Mª Antonia Padial, Dra. · Hospital del Norte, Infanta Sofía

  • Raquel López, Dra. · Complejo Hospitalario La Coruña

  • Carlos Colás, Dr. · Hospital Clínico Lozano Blesa

  • Ignacio Pérez, Dr. · Hospital Royo Vilanova

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2017-05-25
Completion
2017-05-25

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02488447 on ClinicalTrials.gov